Skip to main content
. 2021 Apr 23;12(4):e00337. doi: 10.14309/ctg.0000000000000337

Figure 1.

Figure 1.

Flowchart of patient selection. DAA, direct-acting antiviral; HCC, hepatocellular carcinoma; MRI, magnetic resonance imaging; SVR, sustained virological response.